MIMS news

New single-tablet option for hepatitis C

New single-tablet option for hepatitis C

Zepatier (elbasvir/grazoprevir) is a once-daily, single-tablet...

NICE approves apremilast for refractory psoriasis

NICE approves apremilast for refractory psoriasis

In new guidance NICE recommends the use of apremilast...

New biologic option for Crohn's disease

New biologic option for Crohn's disease

Patients with moderately to severely active Crohn's...

Infographic: Long-term benzodiazepine use widespread, finds study

Infographic: Long-term benzodiazepine use widespread, finds study

Long-term use of benzodiazepines is a significant problem...

Start brimonidine gel at low dose in rosacea, cautions MHRA

Start brimonidine gel at low dose in rosacea, cautions MHRA

Treatment with the topical rosacea treatment brimonidine...

Earn 5 CPD credits at free MIMS workshop on mental health and type 2 diabetes

Earn 5 CPD credits at free MIMS workshop on mental health and type 2 diabetes

Healthcare professionals are invited to attend a complimentary...

Low-dose desmopressin launched as first treatment for nocturia in over 65s

Low-dose desmopressin launched as first treatment for nocturia in over 65s

Noqdirna is a new low-dose, orally disintegrating formulation...

Lower recommended dose for etoricoxib

Lower recommended dose for etoricoxib

The recommended dose of Arcoxia (etoricoxib) has been...

Infographic: Smoking cessation prescriptions fall 35% in 10 years

Infographic: Smoking cessation prescriptions fall 35% in 10 years

Healthcare professionals are handing out fewer prescriptions...

Newly launched once-daily Parkinson's adjunct 'could simplify treatment'

Newly launched once-daily Parkinson's adjunct 'could simplify treatment'

Prescribers can now consider adding opicapone (Ongentys)...

New injectable antibody treatment for asthma

New injectable antibody treatment for asthma

Cinqaero (reslizumab) can be prescribed as add-on therapy...

BTS/SIGN asthma guidance updated with new treatment recommendations

BTS/SIGN asthma guidance updated with new treatment recommendations

The 2016 edition of the Scottish Intercollegiate Guidelines...

Infographic: Prescription stimulant abuse in UK 'highest in Europe'

Infographic: Prescription stimulant abuse in UK 'highest in Europe'

Almost one in 10 Britons has abused prescription stimulants,...

New NICE guidance aims to help GPs treat patients with multiple conditions

New NICE guidance aims to help GPs treat patients with multiple conditions

Tailored management plans that put patients at the...

MHRA: double emergency contraceptive dose in women taking enzyme inducers

MHRA: double emergency contraceptive dose in women taking enzyme inducers

Women needing levonorgestrel-containing emergency contraception...

New HPV vaccine targets nine virus types

New HPV vaccine targets nine virus types

The Gardasil 9 vaccine has activity against nine human...

Summaries of NICE bowel disease guidance published by MIMS

Summaries of NICE bowel disease guidance published by MIMS

GPs treating patients with inflammatory bowel disease...

HIV drug first to be approved in UK for pre-exposure prophylaxis

HIV drug first to be approved in UK for pre-exposure prophylaxis

Truvada (emtricitabine/tenofovir) is indicated in combination...

New class of narcolepsy treatment reaches prescribers

New class of narcolepsy treatment reaches prescribers

Patients with narcolepsy can now be prescribed a new...

Flu vaccines for 2016/17 season

Flu vaccines for 2016/17 season

Flu vaccine listings in MIMS have been updated to reflect...

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.